Atlas Trials

Predicting Response of Metastatic Triple Negative Breast Cancer to Immunotherapy Based on Patients Cytokine Profile

Clinical trial NCT04250818 · SUSPENDED

Trial details

NCT number
NCT04250818
Sponsor
Texas Tech University Health Sciences Center, El Paso
Status
SUSPENDED
Study type
OBSERVATIONAL
Metastatic Triple-Negative Breast Cancer
Start date
2019-07-02
Primary completion
2021-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.